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Abstract: Maintaining adequate daily protein intake is important to maintain muscle mass throughout
the lifespan. In this regard, the overnight period has been identified as a window of opportunity
to increase protein intake in the elderly. However, it is unknown whether pre-sleep protein intake
affects next-morning appetite and, consequently, protein intake. Therefore, the purpose of the current
study was to investigate the effects of a pre-sleep protein drink on next-morning appetite, energy
intake and metabolism. Twelve older individuals (eight males, four females; age: 71.3 ± 4.2 years)
took part in a single-blind randomised cross-over study. After a standardised dinner, participants
consumed either a 40-g protein drink, isocaloric maltodextrin drink, or placebo water control before
bedtime. Next-morning appetite, energy intake, resting metabolic rate (RMR), respiratory exchange
rate (RER), and plasma acylated ghrelin, leptin, glucose, and insulin concentrations were assessed. No
between-group differences were observed for appetite and energy intake at breakfast. Furthermore,
RMR, RER, and assessed blood markers were not significantly different between any of the treatment
groups. Pre-sleep protein intake does not affect next-morning appetite and energy intake and is
therefore a viable strategy to increase daily protein intake in an older population.
Keywords: pre-sleep protein; sarcopenia; ageing
1. Introduction
Age-related declines in skeletal muscle mass (sarcopenia) and strength (dynapenia) are positively
associated with functional dependency, frailty, falls, metabolic disease, and early death [1–5]. Sarcopenia
progression is underpinned by aspects of primary chronological ageing or secondary ageing (i.e.,
biological factors including nutrition and inactivity). Factors related to secondary ageing such as
inactivity [6], a reduced energy/protein intake [7] and the presence of chronic low-grade inflammation [8]
can be targeted and either slowed or reversed through interventions. The rapid global expansion in the
number of older individuals is expected to present an unprecedented burden for national healthcare
systems [9,10]. Indeed, in the UK alone, costs associated with sarcopenia are currently estimated to be
in excess of £2.5 bn per annum [11]. Hence, the development and/or refinement of strategies to mitigate
sarcopenia is of the utmost importance for healthy population ageing and socio-economic prosperity.
The maintenance of skeletal muscle mass hinges on the fine balance between rates of muscle
protein synthesis (MPS) and breakdown (MPB). In younger individuals, dietary amino acid provision
alone or in close proximity to resistance exercise has the ability to increase MPS and suppress MPB,
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leading to skeletal muscle accretion over time. This anabolic response to dietary protein is, however,
blunted in older compared with younger individuals, such that a greater protein dose is needed to
elicit a similar muscle anabolic response. A retrospective study by Moore and colleagues revealed
that maximal stimulation of MPS occurred at 0.24 g·kg body mass−1 and 0.40 g·kg body mass−1 in
young and older individuals, respectively [12]. Based on these per meal protein intakes, it has been
suggested that the current recommended dietary allowance (RDA) for protein of 0.8 g·kg−1·day−1 is
suboptimal for the maintenance of skeletal muscle mass with advancing age. However, increasing
protein intakes up to 1.2–2.0 g·kg−1·day−1 has been shown to reduce long-term lean mass loss in
the elderly [13], and has been shown to have no negative side-effects on health outcomes such as
kidney function [14]. Oftentimes the overnight period is overlooked as a window of opportunity to
increase protein intake. Recently, it was shown that pre-sleep protein ingestion in older individuals is
successfully digested, absorbed and incorporated in de novo protein synthesis during the overnight
period [15]. Thus, the overnight period, which under normal circumstances is linked to postabsorptive
muscle catabolism, could be used to maximise muscle anabolism with important implications in
sarcopenia [16,17]. In addition to the potential for overnight muscle anabolism, pre-sleep protein
ingestion has been reported to increase next morning resting metabolic rate (RMR) and fat oxidation,
potentially conferring beneficial changes in body composition over time [18].
At present, the effect of pre-sleep protein ingestion on next morning appetite and metabolic health
parameters in older individuals is unclear. Protein consumption has been suggested to induce feelings
of satiety which can lead to a reduced caloric intake during subsequent meals [19,20]. However, in
young and older individuals next-morning appetite, as assessed through the visual analogue scale,
was not affected by pre-sleep protein ingestion [15,21]. Besides protein’s potential satiating effect,
protein consumption can increase RMR which is positively associated with the size of a self-determined
meal [22]. As older individuals exhibit reductions in appetite due to alterations in physiological
(impaired sensory perception and chewing capability), psychosocial (loneliness), and orexigenic
and anorexigenic hormonal factors (ghrelin, leptin) [23–25], it is imperative to understand whether
ingestion of a large dose of pre-sleep protein would further impact next-morning protein/energy
intake. If pre-sleep protein consumption attenuates appetite and, consequently, energy/protein intake
at breakfast the next morning, it might render pre-sleep protein ingestion counterproductive, as this
could possibly hinder skeletal muscle maintenance.
Therefore, the aim of the present study was to determine whether a pre-sleep casein protein
beverage would influence next-morning indices of appetite, energy intake and metabolism in older
individuals compared with an energy-matched, protein-free drink and a noncaloric placebo drink. We
hypothesized that pre-sleep casein protein and an energy-matched carbohydrate drink would increase
feelings of satiety in the immediate post-prandial period compared with a non-energetic placebo but
would not adversely affect next morning indices of appetite, ad libitum energy intake, or metabolic
parameters in older individuals.
2. Materials and Methods
2.1. Participants
Twelve healthy older participants (8 male) (age: 71.3 ± 4.2 yrs; body mass: 71.1 ± 13.4 kg; BMI:
23.7 ± 3.4) were recruited from the local Birmingham (UK) community. Participants were excluded
from study participation if they performed regular structured training more than three times a week,
smoked, had Type I/II diabetes, or any medical condition that could cause discomfort in response
to food ingestion. Furthermore, participants were excluded if they presented an eating disorder,
allergy or food intolerance to any of the ingredients present in the pre-sleep beverages, standardised
dinners or ad libitum breakfast. Participants provided written informed consent and general health
questionnaires before the start of any experimental trials. Ethical approval for the present study was
granted by the University of Birmingham School of Sport, Exercise and Rehabilitation Science Research
Nutrients 2020, 12, 90 3 of 14
Ethics Committee (ERN_18-1221) and the study was completed in accordance with the Declaration
of Helsinki.
2.2. Study Design
Following a preliminary visit to assess participants’ study eligibility, anthropometric characteristics,
physical function and dietary habits, participants underwent 3 experimental trial visits in a randomized
single-blind crossover fashion. Participants were randomized using the randomization.com website,
creating random and balanced permutations of treatments for each subject. The evening prior to each
experimental trial visit participants were provided with a standardised dinner and pre-sleep treatment
beverage. The following morning participants attended the laboratories at the School of Sport, Exercise
and Rehabilitation Sciences at 07:00 to undergo RMR measurements followed by multiple blood
sampling and the consumption of an ad libitum breakfast. Subjective measurements of appetite were
carried out the evening prior and during the experimental trial visit. Experimental trials were identical,
apart from the pre-sleep treatment beverage and separated by 7–10 days. All study visits took place at
the School of Sport, Exercise and Rehabilitation Sciences of the University of Birmingham. An overview
of the experimental design is provided in Figure 1.
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Figure 1. Timeline of an experimental visit.
2.3. Preliminary Visit
Participants met with the principal researcher prior to study enrolment to discuss the study
procedures and confirm eligibility. Participants were asked to complete a general health questionnaire
and food preference form. Following this, participants’ height, body mass and BMI were obtained.
A short physical performance battery (SPPB) [26] was completed to ensure participants’ basic levels of
physical independence and gave scores (1–4) for balance, gait speed and leg strength. To assess habitual
dietary intake, participants were asked to complete a 3-day weighed food diary to be completed.
2.4. Experimental Visits
2.4.1. Standardization of Evening Meal
A standardised dinner (50% CHO, 32% FAT, 18% PROT) was provided to be consumed the evening
prior to each experimental visit. Energy provision was manipulated based upon the obtained food
diaries to match the participant’s habitual energy intake during dinne . Food diaries were analysed
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using Dietplan (Dietplan 7, Forestfield Software Ltd., Horsham, UK) and macronutrient breakdown
was determined.
2.4.2. Pre-Sleep Beverages
Participants were asked to consume 1 of 3 pre-sleep treatment beverages in a randomised cross-over
fashion at 22:00 the evening prior to each experimental trial visit. Beverages consisted of either water
(WP), 48 g of casein protein powder (MyProtein, Northwich, UK) providing a 40 g protein-dose (CP),
or 42 g of maltodextrin powder (MyProtein, Northwich, UK) isocaloric to the casein drink (MD).
Participants were given a shaker to take home and instructed to mix the casein or maltodextrin powder
with 400 mL of water. Non-caloric vanilla flavouring (MyProtein, Northwich, UK) was added to
the treatment beverages to improve palatability. A 40-g casein protein-dose was chosen based upon
previous research findings demonstrating its ability to effectively stimulate overnight MPS in older
adults [15]. The nutritional content of each treatment beverage is presented in Table 1.
Table 1. Nutritional content of bedtime beverages. (CP: Casein Protein, MD: Maltodextrin, WP:
Water Placebo).
Energy (kcal) Carbohydrate (g) Protein (g) Fat (g)
CP 168 1.92 40 0.72
MD 168 42 0 0
WP 0 0 0 0
2.4.3. Subjective Measurement of Appetite and Sleep Quality
Feelings of appetite and thirst were assessed using a 100 mm visual analogue scale (VAS) covering
12 questions regarding hunger, fullness, desire to eat and thirst. Each question was accompanied by
two opposing statements interspersed by a 100 mm horizontal line. Participants were instructed to
mark the 100 mm VAS at the point most accurately representing their current feeling. The distance
between the mark and beginning of the 100 mm VAS was measured to determine a score between 0
and 100. For comparison, a baseline VAS for pre-sleep appetite and sleep quality in the absence of a
pre-sleep beverage was performed in the week leading up to the first experimental trial. During each
experimental trial visit, an appetite VAS was completed at the following 12 consecutive time points:
immediately before, after and 30 min after pre-sleep treatment beverage consumption, upon waking,
upon arrival at the laboratory, post-RMR measurement, pre-breakfast, immediately post-breakfast,
30 min post-breakfast, pre-lunch, pre-dinner and finally pre-bedtime. VAS’s are shown to have high
validity and reproducibility in the measurement of subjective appetite [27]. As the focus of the current
investigation was hunger and desire to eat, only the first 4 questions of the VAS relating to these domains
were included for analysis. VAS scores for appetite were split into two time-frames; pre-treatment
(22:00) to pre-breakfast (08:50), and post-breakfast (09:50) to pre-sleep. Therefore, two baseline values
were used in the statistical analyses, i.e., the pre-treatment value (22:00) and post-breakfast value
(09:05). These timeframes are referred to as time-frame 1 and time-frame 2, respectively, throughout
the manuscript.
Sleep quality was determined using the Leeds Sleep Evaluation Questionnaire (LSEQ) [28],
consisting of 10 questions split into four domains (getting to sleep, quality of sleep, waking from
sleep and behaviour following wakefulness). A 100 mm VAS was used to determine the response
to each question, and an average score was calculated for each domain. Participants completed one
baseline LSEQ upon waking in the week leading up to the experimental trial, and on the morning of
the experimental trial.
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2.4.4. Resting Metabolic Rate Measurement
Participants rested supine for 30 min in a supine position on a bed in a quiet, temperature regulated
(22–24 ◦C), dim lit room. Expired gasses were collected over the final 20 min of the measurement
period using a mouthpiece attached to a Douglas bag. A calibrated gas analyser was used to determine
the percentage of O2 and CO2 in the expired air. Volume and temperature of expired air was assessed
using a dry gas meter, and barometric pressure of the laboratory determined in which gas analysis
was taking place. Participants were instructed to lie as still as possible, breathe normally, remain
quiet and stay awake. The Weir formula [29] was used to calculate RMR and accordingly, resting
energy expenditure.
2.4.5. Ad Libitum Breakfast and Assessment of Energy Intake
An ad libitum breakfast was provided to participants during each experimental visit. To determine
energy intake and macronutrient composition, all breakfast items were weighed before and after
consumption, and analysed using Dietplan software (Dietplan 7, Forestfield software Ltd., UK).
Participants were seated in a comfortable, quiet environment and instructed to eat as much or as little
as they desired. The breakfast provided consisted of the following components: water, Kellogg’s
cornflakes, Sainsbury’s medium white bread, Sainsbury’s raspberry jam, Sainsbury’s semi-skimmed
milk (all Sainsbury’s Stores Ltd.), Clover margarine, and yoghurt (Danone Activia). Participants were
unaware that their food consumption was being measured in order to avoid any confounding factors
2.4.6. Blood Sampling and Analyses
Venous blood samples were obtained from an antecubital forearm vein at each experimental trial
visit immediately before, immediately post and 30 min post ad libitum breakfast consumption. Ten ml
blood samples were obtained and decanted evenly between serum-separator and EDTA vacutainers
(BD, Oxford, UK), centrifuged at 3000 RPM for 10 min at 4 ◦C, and stored at −80 ◦C. Plasma glucose
concentrations were analysed in duplicate using an RX Daytona+ analyser. Plasma acylated ghrelin
and plasma leptin were analysed using commercially available enzyme-linked immunosorbent assays
(ghrelin: Bertin Pharma, Montigny le Bretonneux, France; leptin: Mercodia AB, Uppsala, Sweden),
following the manufacturer’s instructions. Samples were batch analysed and samples from each
participant were analysed on the same plate. The intra-and inter-assay coefficient of variation for
acylated ghrelin and leptin were <5% and 10%, respectively. Plasma insulin concentrations were
determined using a commercially available enzyme-linked immunosorbent assay according to the
manufacturer’s instructions (R&D Systems Inc., Minneapolis, MN, USA). All plasma analyses results
are presented for n = 9 as some blood samples were missing for 3 participants due to cannula issues.
2.5. Statistics
All statistical analyses were completed using Graphpad Prism (Version 8.3). One-way repeated
measures ANOVAs were conducted to examine differences in RER, RMR, subjective ratings of sleep
quality, relative energy intake at breakfast and markers of insulin resistance. Two-way repeated
measures ANOVAs assessed interactions between time-point and condition for subjective hunger
scores and blood plasma analyses following consumption of breakfast. Pearson’s correlational analysis
was performed to determine whether pre-breakfast ratings of hunger correlated with actual energy
intake at breakfast. Tukey post-hoc analysis was conducted to identify specific differences where a
main effect or interaction was found. Alpha level was set to p < 0.05. All data are reported as mean ±
standard error and error bars on figures are indicative of standard error of man.
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3. Results
3.1. Appetite and Sleep Quality
Throughout time-frames 1 and 2, no between group differences were found for all four questions.
During time-frame 1, hunger (Figure 2A) was significantly elevated from baseline at 08.50 in all three
groups (p < 0.02 for all three groups), at 08:30 in MD (p = 0.016) and WP (p = 0.002), and at 08:00
in WP (p = 0.002). Satisfaction (Figure 2B) was significantly decreased from baseline values at 08:30
(p = 0.039) and 08:50 (p = 0.009) in CP, at 08:00 (p = 0.0038) and 08:50 (p = 0.009) in MD, and at 08:00
(p < 0.001), 08:30 (p < 0.001) and 08:50 (p < 0.001) in WP. Fullness (Figure 2C) was significantly lower
compared with baseline values for CP, MD, and WP at 8:00, 08:30, and 08:50 (p < 0.029 for all), whilst
significantly increased at 22:15 (p = 0.029) and 22:30 (p = 0.048) in CP only. The desire to eat (Figure 2D)
was increased from baseline at 08:00, 08:30, and 08:50 in both MD and WP (p < 0.02 for all), whilst only
increased at 08:30 (p = 0.009) and 08:50 (p = 0.002) in CP. During time-frame 2, values at pre-lunch
and pre-dinner for all three groups were significantly different from their respective baseline values at
09.05h for all questions (p < 0.004 for all). Satisfaction and fullness were, respectively, increased at
09.35h (p = 0.044) and decreased (p = 0.0499) from baseline values in CP only.
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3.2. Energy Intake and Metabolic Measurements 
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breakfast were observed in any of the experimental conditions (CP: r = −0.129, p = 0.689; MD: r = 
Figure 2. Subjective ratings of hunger (A), satisfaction (B), fullness (C) and desire to eat (D) obtained
via the 100 mm visual analogue scale. Arrows represent the consumption of the pre-sleep treatment
beverage and ad libitum breakfast, respectively. Data are presented as means± SEM. No between-group
significance was apparent, within group differences are stated in the results Section 3.1.
Sleep quality, as assessed by the four LSEQ domains, was not affected by any of the treatment
beverages (GTS: p = 0.963, QOS: p = 0.926, WFS: p = 0.156, BFW: p = 0.883). Furthermore, baseline
sleep quality and s eep quality prior to ny of the exper mental visits did not differ, sugge tin that
consumption of a pre-sleep beverage did not impact sleep qu lity. Sleep quality data was uploaded as
a supplementary file (Supplem ntary Table S1).
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3.2. Energy Intake and Metabolic Measurements
Absolute total energy intake at breakfast was not different across the treatment groups (Figure 3A),
with a similar response for relative carbohydrate, fat and protein intake (Figure 3B). No differences
were observed between the relative protein, carbohydrate and fat intake of the experimental ad
libitum breakfast and habitual breakfast consumption, assessed by the 3-day weighed food diaries
(Supplementary Table S2). Furthermore, no significant relationship between the subjective ratings of
hunger before the experimental breakfast and subsequent energy intake at breakfast were observed in
any of the experimental conditions (CP: r = −0.129, p = 0.689; MD: r = −0.099, p = 0.759; WP: r = −0.119,
p = 0.712.). No significant differences between groups were observed for RMR (p = 0.348) and RER
(p = 0.874) (Figure 3C,D).
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Figure 3. (A) Absolute total energy intake and (B) relative macronutrient intake at the ad libitum
breakfast. (C) resting metabolic rate (RMR) and (D) respiratory exchange ratio (RER) as measured by
indirect calorimetry. # represent individual values within each experimental trial, subject numbers are
placed adjacent to the corresponding circle. Figures represent mean values with SEM.
3.3. Glucose, Insulin, Ghrelin and Leptin Response
No overall and time-point specific between-group differences were observed for any of the plasma
analyses (Figu e 4). Glucos was significantly elevated from pr to 30 min post (p = 0.023) and from
immediately po t to 30 min post (p = 0.04) breakfast consumption in MD only. Insul c ncentrations t
30 min post breakfast consumption were significantly increased from pre (p < 0.001) and immediately
post br akfast (p < 0.043) consumption values in all thr e groups. Plasma in ulin concentrations
in MD wer elevated immediately ost compared with pre breakfast values (p = 0.006). Acylated
plasma ghrelin co centrations wer ecreased 30 min after breakfas consumption compared with
baseline values in CP (p = 0.038). In MD acylated plasma ghrelin concentrations signific n ly decreased
from immediately post to 30 min post breakfast consumption (p = 0.012), whilst acylated plasma
ghrelin concentrations in WP were lower 30 min post compared with pre (p = 0.029) and immediately
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post (p = 0.012) breakfast values. No significant within group differences were found for plasma
leptin concentrations.Nutrients 2019, 11, x FOR PEER REVIEW 8 of 14 
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post. Values are represented as mean with SEM.
4. Discussion
Adequate dietary protein intake with age is important to maintain skeletal muscle mass. The
present study comprehensively investigated the effects of a pre-sleep protein beverage containing 40 g
of casein protein on next-morning appetite levels. In our hands, a pre-sleep protein beverage did not
negatively affect next-morning appetite as determined by the consumption of an ad libitum breakfast,
visual analogue scales, and plasma ghrelin, leptin, insulin and glucose concentrations. Furthermore,
no differences were found in RMR and RER measurements the morning after consuming any of the
pre-sleep treatment beverages. Therefore, the consumption of a pre-sleep protein beverage could be a
viable strategy to maintain or increase protein intake without inferring negative effects on next-day
calorie consumption.
Protein nutrition is key to maintain muscle mass and attenuate the progression towards
sarcopenia [30]. The favourable changes induced by dietary protein intake in older individuals
reach beyond those observed on muscle mass [7] and body composition [31] and include reductions in
plasma triacylglycerols, total cholesterol, very low-density lipoproteins and hepatic lipid content [32].
This raises a clear case for protein consumption to be above the current RDA of 0.8 g·kg−1·day−1 in older
individuals to maintain overall health. Recently, the overnight period has been identified as a potential
time-frame to increase protein intake. Indeed, several studies in both young and older individuals
have shown the ability of an overnight nasogastric or pre-sleep protein feed to induce an increased
MPS response during an otherwise catabolic period [21,33,34]. Nevertheless, promoting a pre-sleep
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feeding strategy would be detrimental to muscle maintenance if it were to decrease next-morning
appetite and consequently protein intake. The present study thoroughly investigated appetite feelings
the day following the consumption of a bedtime protein beverage and found no adverse effects on
next-morning appetite when compared with a water placebo or isocaloric maltodextrin drink. Our
results confirm earlier suggestions from Kouw and colleagues [34] and Madzima et al. [35] showing no
effects of a pre-sleep protein drink on next morning indices of appetite. Studies that have reported a
satiating effect of protein on next morning appetite might have been influenced by the macronutrient
composition of the pre-sleep treatment, or the timing and mode of protein delivery. In this regard,
Ormsbee et al. [36] found that when chocolate milk is consumed before bedtime, next morning appetite
is reduced in young females. Furthermore, Groen et al. [33] showed reductions in next-morning
appetite in elderly men following intragastric administration of 40 g of casein during sleep. The
presence or absence of a satiating effect inflicted by protein consumption is likely determined by
the amount of time elapsed between pre-sleep protein consumption and next-morning measures of
appetite. It is therefore not surprising that these feelings of fullness with protein intake typically occur
during the acute postprandial period [37–39]. Further evidence supporting the lack of a satiating
protein effect in the current study can be found in the absence of a significant between-group difference
in total energy and relative macronutrient consumption during the ad libitum breakfast, similar to
observations in younger individuals in the study of Lay et al. [40]. Finally, energy intake tended to
be higher in response to habitual breakfast intake as opposed to the trial breakfast, which might be
a consequence of the relatively limited number of foods served at the trial breakfast. To overcome
this hurdle, future investigations should include a wider variety of foods to match personal dietary
preferences. It is important to note that the present study utilised visual analogue scales to assess
subjective feelings of hunger and appetite, which might not correlate with energy intake [41]. This is
reflected in our inability to find a correlation between pre-breakfast hunger ratings and subsequent
energy intake, in spite of no between-group differences between these variables. Future research
should ensure actual energy intake is assessed alongside appetite for the entirety of the following day
after pre-sleep protein ingestion, not just breakfast, as one is not necessarily indicative of the other.
Sleep is a key aspect in maintaining a healthy lifestyle. Not only does sleep play an important part
in regulating our internal molecular mechanisms (e.g., hormone release), it also drives our circadian
rhythms, and consequently whole-body metabolism [42]. It has been shown previously that a disrupted
or irregular sleep pattern can lead to obesity and insulin resistance [43,44]. Factors contributing to
these disrupted sleep patterns are multifactorial and include dietary habits [45]. In this regard, a
study by Crispim and colleagues revealed a negative relationship between nocturnal food intake and
sleep quality in healthy individuals [46]. In the present study sleep quality was assessed using the
LSEQ, and was not significantly different between any of the treatment groups and from baseline
(pre-intervention) measurements, suggesting no effect of the pre-sleep beverage on overall sleep quality
(Supplementary Table S1). Nevertheless, multiple participants anecdotally reported a disturbed sleep
after consuming one of the provided treatment beverages. The amount of liquid (400 mL) consumed
before bed-time led to increased urination at night. These anecdotal reports inferring sleep disruption
could be associated with a deviation from habitual dietary routines. A study by Adam [47] elegantly
showed that individuals who habitually ate before bedtime showed a decreased sleep quality when
consuming non-caloric capsules instead. The opposite held true too, individuals who were accustomed
to abstaining from any pre-sleep food intake became more sleep deprived when drinking milk before
bedtime. The authors concluded that a departure from a person’s habitual evening food intake would
impair subsequent sleep. Therefore, the question remains whether these anecdotal reports of increased
urination during the night, would have persisted and impacted upon overall sleep quality if a pre-sleep
beverage were to be provided chronically.
Feelings of hunger are strongly dictated by the interplay of several hormones, most notably insulin,
leptin and ghrelin. Insulin is secreted by the pancreatic beta cells and plays a role in glucose metabolism,
leptin is secreted by adipose tissue and is a satiety factor, whilst ghrelin is primarily secreted by the
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stomach and duodenum and is an orexigenic ligand [48]. As amino acids are believed to suppress
feelings of hunger, we measured plasma leptin, acylated ghrelin, glucose, and insulin concentrations
before, after and 30 min after the ad libitum breakfast consumption, and whether these parameters
would be affected by the pre-sleep treatment beverage. It is well-established that a pre-prandial
increase in circulatory ghrelin concentrations is observed before meal-consumption [49]. In the present
study, no between-group differences were observed in pre-breakfast concentrations of plasma acylated
ghrelin, leptin, or any of the other measured blood markers. These observations strongly suggest that
the pre-sleep beverage did not affect any of the hunger related hormones (pre-breakfast). It is therefore
not surprising that calorie intake at breakfast was equal between treatment groups. Plasma acylated
ghrelin concentrations were decreased from either pre-breakfast values in CP and WP or immediately
post-breakfast values in MD. This finding is in line with other research showing a postprandial
nadir in plasma ghrelin concentrations 60 min after consuming a mixed-macronutrient meal [50].
Plasma insulin concentrations were increased 30 min after breakfast consumption in the present study,
irrespective of treatment group, which is supported by previous findings [51,52]. Furthermore, an
inverse relationship between insulin and ghrelin levels has previously been reported. A study by
Saad et al. [53] demonstrated that an insulin infusion led to suppressed ghrelin concentrations up to
15 min after cessation of the infusion. This inverse relationship between plasma insulin and acylated
ghrelin levels was also observed in the present study. Plasma leptin concentrations did not change
in our study, which is likely due to the relatively short time-frame over which blood samples were
collected. A study by Romon and colleagues [54] showed a rise in leptin concentrations four hours
after meal-consumption. Further research is required to fully elucidate the acute postprandial effects
of a pre-sleep protein beverage on the regulation of appetite hormones, and how this relates to feelings
of satiety. This could inform the optimal dose and timing of a pre-sleep protein beverage without
affecting next-morning appetite.
Protein and energy content of a meal have been shown to influence food-induced
thermogenesis [55]. In the present study, we anticipated to see an effect of the pre-sleep protein,
and possibly carbohydrate, beverage on RMR and RER. However, we were unable to detect any
differences between treatment groups for the aforementioned variables. Studies investigating the
effects of a pre-sleep snack on next-morning RMR measurements are equivocal, with some showing an
increase [36] and others no effect [40,56,57]. Discrepancies in these findings are likely related to the
elapsed time between pre-sleep snack consumption and RMR measurement, with shorter time-frames
increasing the likelihood of finding an effect. Indeed, a study conducted by Ormsbee and colleagues
in young female runners found an increase in next-morning RMR when 335 mL of chocolate milk
(containing 12 g of protein and 30 g of CHO) was consumed 30 min before bedtime and ~7h before
the RMR measurement [36]. In contrast, a study by Lay and colleagues failed to observe an increase
in RMR when a pre-sleep snack was consumed ~10 h earlier in mildly overweight young men [40].
These findings were confirmed by Kinsey et al, who reported no increase in RMR ~8 h post bedtime
snack consumption in obese young men [56]. The absence of any changes in next-morning RMR
is not surprising as previous metabolic ward investigations have demonstrated that diet-induced
thermogenesis returns to basal values within six hours of consuming a pre-sleep snack [58]. Finally,
sleep quality and sleep duration can impact RMR, with shorter sleeping times leading to a decrease
in RMR [59]. As sleep quality was unaffected by the treatment beverage, this likely did not impact
RMR measurements. Besides RMR, next-morning substrate utilisation (RER) was assessed in the
present study, and was not affected by the pre-sleep treatment beverage. The absence of any effect
on RER is conceivably a consequence of unaltered insulin concentrations between groups. Substrate
utilisation is strongly dictated by circulatory insulin levels, with elevated insulin concentrations shifting
substrate utilisation towards carbohydrate oxidation [60]. In this regard, a study by Pennings et al. [61]
has previously shown that casein ingestion resulted in a lower insulinemic response compared with
whey protein and casein hydrolysate. This decreased insulinemic response could shift fuel utilization
towards increased fat oxidation rates and explain the results observed by Madzima and colleagues
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demonstrating increased RER values when whey protein or carbohydrates were consumed pre-sleep
compared with a placebo control [18]. It could hence be speculated that casein ingestion would lead to
lower plasma insulin concentrations compared with the isocaloric carbohydrate drink. Nevertheless,
next-morning plasma glucose and insulin concentrations were similar between treatments. This is to
be expected as insulin and glucose levels return to baseline levels ~2 h after an oral glucose tolerance
test [62]. Therefore, the comparable plasma insulin concentrations between treatments likely underlies
the similar RER values.
5. Conclusions
The results of the present study suggest that 40 g of casein protein ingested as a beverage prior to
sleep, does not adversely affect sleep quality or next-morning indices of appetite, energy intake or
metabolism in older individuals. As such, the implementation of pre-sleep protein strategies to increase
daily protein consumption in older individuals is a viable option and should not elicit reductions in
energy (and subsequently protein) intake at breakfast time or other meals the following day. Future
research should look to expand these findings by investigating different food forms of pre-sleep protein
snack (liquid vs. solid), as well as assessing energy and protein intake, appetite, and activity throughout
the entirety of the day following experimental visits to determine whether pre-sleep protein has any
effect on whole-day behaviours. Furthermore, based upon the above and previous evidence of the
acute efficacy of a pre-sleep protein snack on muscle anabolism, more longitudinal studies should
explore whether bedtime protein consumption could attenuate the sarcopenic progression.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/12/1/90/s1,
Table S1: LSEQ questions, Table S2: Habitual dietary protein intake.
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